全球冠状动脉支架市场 - 行业趋势及 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Coronary Stents Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球冠状动脉支架市场 - 行业趋势及 2028 年预测

  • Healthcare
  • Upcoming Report
  • Mar 2021
  • Global
  • 350 页面
  • 桌子數： 60
  • 图号： 220
立即购买 立即购买

Coronary Stents Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 1 –2028
Diagram Market Size (Base Year)
 USD MILLION
Request
Diagram Market Size (Forecast Year)
 USD 30.23 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co KG
  • B. Braun Melsungen AG

>全球冠状动脉支架市场，按类型（双疗法支架、生物可吸收血管支架、药物洗脱支架 (DES)、生物工程支架和裸金属支架）、吸收率（慢吸收 DES 和快吸收 (DES)）、材料（不锈钢、钴合金金属、金、钽、镍钛合金和聚合物）、速率（慢吸收支架和快吸收支架）、应用（冠状动脉疾病和外周动脉疾病）、输送方式（球囊扩张支架和自膨胀支架）、最终用户（医院、心脏中心等）、国家（美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区）行业趋势和预测（至 2028 年）

冠状动脉支架市场冠状动脉支架市场的市场分析和见解

血管成形术的普及率上升，加上老年人口的增加，推动了冠状动脉支架市场价值的上升。Data Bridge Market Research 分析，冠状动脉支架市场在 2021-2028 年的预测期内将呈现约 7.34% 的复合年增长率。

冠状动脉支架是可膨胀的网状管，插入冠状动脉以调节血液流动或供应。它在手术过程中用于保持动脉畅通并防止血液堵塞。冠状动脉支架由医用级钢制成，一旦插入，就会永久留在动脉中。这是因为组织将开始覆盖皮肤本身的支架状层。如今，几乎每一次血管成形术都会使用冠状动脉支架。

随着心脏病患者人数的增加，冠状动脉支架的需求也大幅增加。老年人口的增加，加上心血管疾病和糖尿病患者的增加，导致冠状动脉支架的需求增加。风险率低，制造成本低，也推动了冠状动脉支架的需求。

支架植入过程中的并发症将减缓市场的增长速度。植入手术的高昂成本将进一步限制增长范围。最近的冠状病毒疫情也对市场产生了负面影响。

本冠状动脉支架市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关冠状动脉支架市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

全球冠状动脉支架市场范围和市场规模

冠状动脉支架市场根据类型、吸收率、材料、速率、应用、交付方式和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

  • 根据类型，冠状动脉支架市场分为双疗法支架、生物可吸收血管支架、药物洗脱支架 (DES)、生物工程支架和裸金属钢。药物洗脱支架 (DES) 进一步细分为紫杉醇和利莫司类药物。
  • 根据吸收率，冠状动脉支架市场分为慢吸收 DES 和快吸收 DES。
  • 根据材料，冠状动脉支架市场分为不锈钢、钴合金金属、金、钽、镍钛合金和聚合物。
  • 根据吸收速率，冠状动脉支架市场分为慢吸收支架和快吸收支架。
  • 冠状动脉支架市场还根据应用分为冠状动脉疾病和外周动脉疾病。
  • 根据输送方式，冠状动脉支架市场分为球囊扩张支架和自膨支架。
  • 市场还根据最终用户细分为医院、心脏中心和其他。

冠状动脉支架市场国家层面分析

对冠状动脉支架市场进行了分析，并按国家、类型、吸收率、材料、速率、应用、交付方式和最终用户提供了市场规模见解和趋势。

冠状动脉支架市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于心血管疾病的发病率不断上升，北美在冠状动脉支架市场占据主导地位。此外，良好的医疗基础设施加上不断提高的研发能力促进了该地区市场的增长。相反，由于亚太地区血管成形术的增加，该地区将在预测期内呈现最高的增长率。糖尿病患者的增加加上饮酒和吸烟等不良的生活方式也促进了市场的增长。

冠状动脉支架市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和冠状动脉支架市场份额分析

冠状动脉支架市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对冠状动脉支架市场的关注有关。

冠状动脉支架市场报告中涉及的主要参与者包括美敦力、雅培、波士顿科学公司或其附属公司、BIOTRONIK SE & Co KG、B. Braun Melsungen AG、Terumo Corporation、STENTYS SA、微创科学公司、Meril Life Sciences Pvt. Ltd.、Vascular Concept.、WL Gore & Associates, Inc.、BD.、ENDOLOGIX LLC.、Translumina.、JOTEC GmbH、Lombard Medical、Xcell Medical Group、Cardinal Health.、Cook 和 Sahajanand Laser Technology Limited (SLTL Group) 以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1. INTRODUCTION

       1.1. OVERVIEW OF THE GLOBAL CORONARY STENTS MARKET
       1.2. MARKET SEGMENTATION & COVERAGE
                1.2.1. CURRENCY AND PRICING 
                1.2.2. LIMITATION
                1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS
       2.2. ARRIVING AT THE GLOBAL CORONARY STENTS MARKET SIZE
                2.2.1. MARKET CRACKDOWN APPROACH 
                2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                2.2.3. DATA TRIANGULATION
                2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
                2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
                2.2.6. PORTER’S FIVE FORCES MATRIX
       2.3. GLOBAL CORONARY STENTS MARKET: RESEARCH SNAPSHOT
       2.4. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW
       4.2. GLOBAL CORONARY STENTS MARKET: KEY PRIMARY INSIGHTS
       4.3. MARKET OVERVIEW
                4.3.1. DRIVERS
                4.3.2. RESTRAINTS
                4.3.3. OPPOTUNITIES
                4.3.4. THREATS
       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. GLOBAL CORONARY STENTS MARKET, BY TYPE

       5.1. OVERVIEW
       5.2. DUAL THERAPY STENT
       5.3. BIORESORBABLE VASCULAR SCAFFOLD
       5.4. DRUG ELUTING STENT (DES)
                5.4.1. PACLITAXEL
                5.4.2. IMUS-BASED DRUGS
       5.5. BIO-ENGINEERED STENT
       5.6. BARE METAL STENT

6. GLOBAL CORONARY STENTS MARKET, BY ABSORPTION RATE

       6.1. SLOW-ABSORPTION DES
       6.2. FAST-ABSORPTION (DES)

7. GLOBAL CORONARY STENTS MARKET, BY MATERIAL

       7.1. OVERVIEW
       7.2. STAINLESS STEEL
       7.3. COBALT ALLOY METAL
       7.4. GOLD
       7.5. TANTALUM
       7.6. NITINOL
        7.7. POLYMERS

8. GLOBAL CORONARY STENTS MARKET, BY RATE

       8.1. OVERVIEW
       8.2. SLOW-ABSORPTION STENTS
       8.3. FAST-ABSORPTION STENTS

9. GLOBAL CORONARY STENTS MARKET, BY APPLICATION

       9.1. CORONARY ARTERY DISEASE
       9.2. PERIPHERAL ARTERY DISEASE

10. GLOBAL CORONARY STENTS MARKET, BY END USER

       10.1. HOSPITALS
       10.2. CARDIAC CENTERS
       10.3. OTHERS

11. GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY

       11.1. COUNTRYWISE CORONARY STENTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                11.1.1. NORTH AMERICA
                            11.1.1.1. U.S.
                            11.1.1.2. CANADA
                            11.1.1.3. MEXICO
                11.1.2. EUROPE
                            11.1.2.1. GERMANY
                            11.1.2.2. FRANCE
                            11.1.2.3. U.K.
                            11.1.2.4. ITALY
                            11.1.2.5. SPAIN
                            11.1.2.6. RUSSIA
                            11.1.2.7. TURKEY
                            11.1.2.8. BELGIUM
                            11.1.2.9. NETHERLANDS
                            11.1.2.10. SWITZERLAND
                            11.1.2.11. REST OF EUROPE
                11.1.3. ASIA-PACIFIC (APAC)
                            11.1.3.1. JAPAN
                            11.1.3.2. CHINA
                            11.1.3.3. SOUTH KOREA
                            11.1.3.4. INDIA
                            11.1.3.5. AUSTRALIA
                            11.1.3.6. SINGAPORE
                            11.1.3.7. THAILAND
                            11.1.3.8. MALAYSIA
                            11.1.3.9. INDONESIA
                            11.1.3.10. PHILIPPINES
                            11.1.3.11. REST OF APAC
                11.1.4. SOUTH AMERICA
                            11.1.4.1. BRAZIL
                            11.1.4.2. REST OF SOUTH AMERICA
                11.1.5. MIDDLE EAST AND AFRICA
                            11.1.5.1. SOUTH AFRICA
                            11.1.5.2. REST OF MIDDLE EAST AND AFRICA
       11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

12. GLOBAL CORONARY STENTS MARKET: COMPETITIVE LANDSCAPE

       12.1. GLOBAL CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.2. U.S. CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.3. EUROPE CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.4. APAC CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.5. SOUTH AMERICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.6. MIDDLE EAST AND AFRICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.7. MERGERS & ACQUISITIONS
       12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
       12.9. EXPANSIONS
       12.10. REGULATORY CHANGES
       12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS            

13. GLOBAL CORONARY STENTS MARKET, COMPANY PROFILES

       13.1. ABBOTT VASCULAR
                13.1.1. OVERVIEW
                13.1.2. SWOT ANALYSIS
                13.1.3. PRODUCT PORTFOLIO
                13.1.4. REVENUE ANALYSIS
                13.1.5. ANALYSTS VIEW
       13.2. SCITECH
                13.2.1. OVERVIEW
                13.2.2. SWOT ANALYSIS
                13.2.3. PRODUCT PORTFOLIO
                13.2.4. REVENUE ANALYSIS
                13.2.5. ANALYSTS VIEW
       13.3. BOSTON SCIENTIFIC CORPORATION
                13.3.1. OVERVIEW
                13.3.2. SWOT ANALYSIS
                13.3.3. PRODUCT PORTFOLIO
                13.3.4. REVENUE ANALYSIS
                13.3.5. ANALYST VIEW
       13.4. MEDINOL LTD
                13.4.1. OVERVIEW
                13.4.2. SWOT ANALYSIS
                13.4.3. PRODUCT PORTFOLIO
                13.4.4. REVENUE ANALYSIS
                13.4.5. ANALYSTS VIEW
       13.5. IVASCULAR SLU
                13.5.1. OVERVIEW
                13.5.2. SWOT ANALYSIS
                13.5.3. PRODUCT PORTFOLIO
                13.5.4. REVENUE ANALYSIS
               13.5.5. ANALYSTS VIEW
       13.6. STENTYS SA
                13.6.1. OVERVIEW
                13.6.2. SWOT ANALYSIS
                13.6.3. PRODUCT PORTFOLIO
                13.6.4. REVENUE ANALYSIS
                13.6.5. ANALYSTS VIEW
       13.7. ELIXIR MEDICAL CORPORATION
                13.7.1. OVERVIEW
                13.7.2. SWOT ANALYSIS
                13.7.3. PRODUCT PORTFOLIO
                13.7.4. REVENUE ANALYSIS
                13.7.5. ANALYSTS VIEW
       13.8. INSPIRE MD
                13.8.1. OVERVIEW
                13.8.2. SWOT ANALYSIS
                13.8.3. PRODUCT PORTFOLIO
                13.8.4. REVENUE ANALYSIS
                13.8.5. ANALYSTS VIEW
       13.9. HEXACATH
                13.9.1. OVERVIEW
                13.9.2. SWOT ANALYSIS
                13.9.3. PRODUCT PORTFOLIO
                13.9.4. REVENUE ANALYSIS
                13.9.5. ANALYSTS VIEW
       13.10. MEDTRONIC
                13.10.1. OVERVIEW
                13.10.2. SWOT ANALYSIS
                13.10.3. PRODUCT PORTFOLIO
                13.10.4. REVENUE ANALYSIS
                13.10.5. ANALYSTS VIEW
       13.11. ORBUSNEICH
                13.11.1. OVERVIEW
                13.11.2. SWOT ANALYSIS
                13.11.3   PRODUCT PORTFOLIO
                13.11.4   REVENUE ANALYSIS
                13.11.5   ANALYSTS VIEW
       13.12. ANDRAMED GMBH
                13.12.1. OVERVIEW
                13.12.2. SWOT ANALYSIS
                13.12.3. PRODUCT PORTFOLIO
                13.12.4. REVENUE ANALYSIS
                13.12.5. ANALYSTS VIEW
       13.13. CORDIS CORPORATION
                13.13.1. OVERVIEW
                13.13.2. SWOT ANALYSIS
                13.13.3. PRODUCT PORTFOLIO
                13.13.4. REVENUE ANALYSIS
                13.13.5. ANALYSTS VIEW
       13.14. ENDOCOR GMBH
                13.14.1. OVERVIEW
                13.14.2. SWOT ANALYSIS
                13.14.3. PRODUCT PORTFOLIO
                13.14.4. REVENUE ANALYSIS
                13.14.5. ANALYSTS VIEW
       13.15. EUROCOR GMBH
                13.15.1. OVERVIEW
                13.15.2. SWOT ANALYSIS
                13.15.3. PRODUCT PORTFOLIO
                13.15.4. REVENUE ANALYSIS
                13.15.5. ANALYSTS VIEW
       13.16. COOK MEDICAL.
                13.16.1. OVERVIEW
                13.16.2. SWOT ANALYSIS
                13.16.3. PRODUCT PORTFOLIO
                13.16.4. REVENUE ANALYSIS
                13.16.5. ANALYSTS VIEW
       13.17. MICROPORT SCIENTIFIC CORPORATION
                13.17.1. OVERVIEW
                13.17.2. SWOT ANALYSIS
                13.17.3. PRODUCT PORTFOLIO
                13.17.4. REVENUE ANALYSIS
                13.17.5. ANALYSTS VIEW
       13.18. DEGANIA SILICONE LTD.
                13.18.1. OVERVIEW
                13.18.2. SWOT ANALYSIS
                13.18.3. PRODUCT PORTFOLIO
                13.18.4. REVENUE ANALYSIS
                13.18.5. ANALYSTS VIEW
       13.19. TERUMO CORPORATION
                13.19.1. OVERVIEW
                13.19.2. SWOT ANALYSIS
                13.19.3. PRODUCT PORTFOLIO
                13.19.4. REVENUE ANALYSIS
                13.19.5. ANALYSTS VIEW
       13.20. MERIL LIFE SCIENCES PVT. LTD.
                13.20.1. OVERVIEW
                13.20.2. SWOT ANALYSIS
                13.20.3. PRODUCT PORTFOLIO
                13.20.4. REVENUE ANALYSIS
                13.20.5. ANALYSTS VIEW
       13.21. ALVIMEDICA
                13.21.1. OVERVIEW
                13.21.2. SWOT ANALYSIS
                13.21.3. PRODUCT PORTFOLIO
                13.21.4. REVENUE ANALYSIS
                13.21.5. ANALYSTS VIEW
       13.22. ELIXIR MEDICAL CORPORATION
                13.22.1. OVERVIEW
                13.22.2. SWOT ANALYSIS
                13.22.3. PRODUCT PORTFOLIO
                13.22.4. REVENUE ANALYSIS
                13.22.5. ANALYSTS VIEW
       13.23. INSITU TECHNOLOGIES INC.
                13.23.1. OVERVIEW
                13.23.2. SWOT ANALYSIS
                13.23.3. PRODUCT PORTFOLIO
                13.23.4. REVENUE ANALYSIS
                13.23.5. ANALYSTS VIEW
       13.24. BIOTRONIK SE & CO. KG
                13.24.1. OVERVIEW
                13.24.2. SWOT ANALYSIS
                13.24.3. PRODUCT PORTFOLIO
                13.24.4. REVENUE ANALYSIS
                13.24.5. ANALYSTS VIEW
       13.25. AMG INTERNATIONAL GMBH
                13.25.1. OVERVIEW
                13.25.2. SWOT ANALYSIS
                13.25.3. PRODUCT PORTFOLIO
                13.25.4. REVENUE ANALYSIS
                13.25.5. ANALYSTS VIEW
       13.26. ARTHESYS
                13.26.1. OVERVIEW
                13.26.2. SWOT ANALYSIS
                13.26.3. PRODUCT PORTFOLIO
                13.26.4. REVENUE ANALYSIS
                13.26.5. ANALYSTS VIEW
       13.27. TRANSLUMINA GMBH
                13.27.1. OVERVIEW
                13.27.2. SWOT ANALYSIS
                13.27.3. PRODUCT PORTFOLIO
                13.27.4. REVENUE ANALYSIS
                13.27.5. ANALYSTS VIEW
       13.28. LEPU MEDICAL
                13.28.1. OVERVIEW
                13.28.2. SWOT ANALYSIS
                13.28.3. PRODUCT PORTFOLIO
                13.28.4. REVENUE ANALYSIS
                13.28.5. ANALYSTS VIEW
       13.29. ACCURA
                13.29.1. OVERVIEW
                13.29.2. SWOT ANALYSIS
                13.29.3. PRODUCT PORTFOLIO
                13.29.4. REVENUE ANALYSIS
                13.29.5. ANALYSTS VIEW
       13.30. CELONOVA BIOSCIENCES, INC.
                13.30.1. OVERVIEW
                13.30.2. SWOT ANALYSIS
                13.30.3. PRODUCT PORTFOLIO
                13.30.4. REVENUE ANALYSIS
                13.30.5. ANALYSTS VIEW
       13.31. MINVASYS
                13.31.1. OVERVIEW
                13.31.2. SWOT ANALYSIS
                13.31.3. PRODUCT PORTFOLIO
                13.31.4. REVENUE ANALYSIS
                13.31.5. ANALYSTS VIEW
       13.32. SVELTE MEDICAL
                13.32.1. OVERVIEW
                13.32.2. SWOT ANALYSIS
                13.32.3. PRODUCT PORTFOLIO
                13.32.4. REVENUE ANALYSIS
                13.32.5. ANALYSTS VIEW
       13.33. B. BRAUN MELSUNGEN AG
                13.33.1. OVERVIEW
                13.33.2. SWOT ANALYSIS
                13.33.3. PRODUCT PORTFOLIO
                13.33.4. REVENUE ANALYSIS
                13.33.5. ANALYSTS VIEW
       13.34. EUCATECH AG
                13.34.1. OVERVIEW
                13.34.2. SWOT ANALYSIS
                13.34.3. PRODUCT PORTFOLIO
                13.34.4. REVENUE ANALYSIS
                13.34.5. ANALYSTS VIEW

13. APPENDIX

14. ABOUT DATA BRIDGE MARKET RESEARCH

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global , By Type (Dual Therapy Stent, Bioabsorbable Vascular Scaffold, Drug Eluting Stent (DES), Bio-Engineered Stent and Bare Metal Stent), Absorption Rate (Slow-Absorption DES and Fast-Absorption (DES)), Material (Stainless Steel, Cobalt Alloy Metal, Gold, Tantalum, Nitino and Polymers), Rate (Slow-Absorption Stents and Fast-Absorption Stents), Application (Coronary Artery Disease and Peripheral Artery Disease), Mode Of Delivery (Balloon-expandable Stents and Self-expanding Stents), End Users (Hospitals, Cardiac Centres and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028 .
The Coronary Stents Market size was valued at USD 0.00 USD Billion in 0.
The Coronary Stents Market is projected to grow at a CAGR of 7.34% during the forecast period of 1 to 2028.
The major players operating in the market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co KG, B. Braun Melsungen AG, Terumo Corporation, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. , Vascular Concept, W. L. Gore & Associates , BD, ENDOLOGIX LLC, Translumina, JOTEC GmbH, Lombard Medical, Xcell Medical Group, Cardinal Health, Cook, Sahajanand Laser Technology Limited -.

浏览相关页面

Banner